SNDL (SNDL) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
27 Oct, 2026Executive summary
Q3 net revenue fell 2.5% YoY to C$238.0M; adjusted operating income was C$5.2M, while reported operating loss included a C$52M non-cash goodwill impairment.
Record quarterly free cash flow was C$20.0M, including a C$10.6M benefit from the initial captive insurance unwind; both retail segments set record gross margins.
Cannabis Operations underperformance prompted a strategic review, a domestic dried-flower exit and cost reductions.
Trailing 12-month net revenue was C$922M; unrestricted cash was C$132M at September 30, with no debt reported.
Financial highlights
Gross profit was C$57.9M, down 9.8% YoY; gross margin was 24.3%, down 2.0 percentage points.
Operating loss was C$48.3M versus C$11.1M; adjusted operating income was C$5.2M versus an adjusted loss of C$9.5M.
Net loss was C$50.8M versus C$13.3M, and adjusted EBITDA was C$15.8M versus C$18.1M.
Free cash flow rose C$3.3M, or 19.5%, YoY; operating cash flow was C$18.6M.
Cash and cash equivalents declined C$50.7M, primarily reflecting strategic investments and share repurchases.
Outlook and guidance
Manufacturing and other operating cost reductions, including at Kelowna, are expected to benefit results in Q4; the facility workforce was reduced by more than 30%.
A strategic review of Cannabis Operations will assess alternatives ranging from asset divestitures to productivity initiatives; production optimization and SG&A right-sizing are underway.
A proposed Ontario resolution, subject to definitive documentation and a C$200,000 penalty, could allow Value Buds franchise growth to resume; retail operations would be deconsolidated while substantially preserving net economics.
Cannabis Retail plans further Value Buds expansion in Alberta and Saskatchewan in 2027; retail optimization is expected to continue through 2026.
A potential C$50M substantial issuer bid was announced; any offer remains subject to approvals and documentation.
Latest events from SNDL
- Shareholders rejected the proposed consolidation despite the board’s marketability and listing rationale.SNDL
AGM 2026 - Revenue and margins declined, but liquidity, share repurchases, and U.S. expansion drive outlook.SNDL
Q2 2026 - Revenue and profit declined, but margin gains, strong liquidity, and initiatives support future growth.SNDL
Q1 2026 - Record revenue, profitability, and cash flow driven by cannabis and retail growth.SNDL
Q4 2025 - First-ever positive operating income and record revenue, led by Cannabis and Liquor Retail growth.SNDL
Q2 2025 - Record gross margin and cannabis growth drive improved profitability and outlook.SNDL
Q2 2024 - Record gross margin and cash flow highlight Q3 2024, with strong Cannabis segment growth.SNDL
Q3 2024 - All resolutions passed, directors elected, and no shareholder questions were raised.SNDL
AGM 2024 - Record gross margin and strong cannabis growth highlight improved Q1 2025 performance.SNDL
Q1 2025